In regard to Marcié et al.: in vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy (Int J Radiat Oncol Biol Phys 2005;61:1603-1606).
作者信息
Ayyangar Komanduri, Nehru Ramasamy, Djajaputra David, Zhen Weining, Enke Charles
出版信息
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):310-1; author reply 311. doi: 10.1016/j.ijrobp.2005.05.002.
PMID:16111605
Abstract
摘要
相似文献
1
In regard to Marcié et al.: in vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy (Int J Radiat Oncol Biol Phys 2005;61:1603-1606).
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):310-1; author reply 311. doi: 10.1016/j.ijrobp.2005.05.002.
2
In vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy.
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1603-6. doi: 10.1016/j.ijrobp.2004.12.034.
3
Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1286; author reply 1287. doi: 10.1016/j.ijrobp.2008.12.008.
4
In regard to Vicini et al. (Int J Radiat Oncol Biol Phys 2007;68:341-346).
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1336-7. doi: 10.1016/j.ijrobp.2007.05.087.
5
In regard to Lee et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. (Int J Radiat Oncol Biol Phys 2003;57:49-60).
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1639; author reply 1639-40. doi: 10.1016/j.ijrobp.2003.11.010.
6
Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1636; author reply 1636-7. doi: 10.1016/j.ijrobp.2003.12.005.
7
Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1273-4; author reply 1274. doi: 10.1016/j.ijrobp.2006.07.1371.
8
Essential dosimetric parameters of liver for the association with radiation-induced liver disease and virus reactivation: in regard to Kim et al. (Int J Radiat Oncol Biol Phys 2007;69:813-819).
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):961; author reply 961-2. doi: 10.1016/j.ijrobp.2008.02.042.
9
In regards to Chen et al.: Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma (Int J Radiat Oncol Biol Phys 2006;66:1408-1414).
Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1584-5; author reply 1585. doi: 10.1016/j.ijrobp.2007.03.015.
10
In regard to Laskar et al.: Nasopharyngeal carcinoma in children: ten years' experience at the Tata Memorial Hospital, Mumbai (Int J Radiat Oncol Biol Phys 2004;58:189-195).
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):686; author reply 686. doi: 10.1016/j.ijrobp.2004.04.055.
Zotero 插件